Mrs Claire Cochran

Mrs Claire Cochran The University of Aberdeen School of Medicine & Dentistry Mrs Claire Cochran Trial Manager work +44 (0)1224 438171 work fax +44 (0)1224 554580

Trial Manager

Bsc Geography (Hons), MsC Public Health (Medicine)

Mrs Claire Cochran

Personal Details

Telephone: +44 (0)1224 438171
Fax: +44 (0)1224 554580
Email: claire.cochran@abdn.ac.uk
hCard

Jump to:

Biography

 

Claire Cochran joined the Unit in October 2006, and took up position as the trial manager on the MAPS (Men After Prostate Surgery) trial. MAPS is a £1.3 million project (Funded by NHS R&D Health Technology Assessment (HTA) Programme) to investigate incontinence in men who have had prostate surgery. MAPS aimed to explore whether physiotherapy can help men who have had these kinds of surgery. 

Claire graduated from Birmingham University in 1998 with a BSc in Physical Geography and has since gained an MSc in Public Health (Medicine) from the University of Aberdeen

In 2008 Claire began a new position in HSRU as the trial manger of EAGLE. EAGLE is an MRC funded international multi-centre pragmatic randomised controlled trial (RCT) to establish whether removal of the lens of the eye (lens extraction) for newly diagnosed Primary Angle Closure Glaucoma results in better patient reported health, vision, lower IOP and other outcomes compared with standard management.  


^ top

Current Research

EAGLE is an international multi-centre pragmatic randomised controlled trial (RCT) to establish whether removal of the lens of the eye (lens extraction) for newly diagnosed Primary Angle Closure Glaucoma results in better patient reported health, vision, lower IOP and other outcomes compared with standard management.

The current standard care for PACG is a stepped approach of a combination of surgery (laser or incisional) and medical management. Initial surgery uses a laser to make a small hole in the iris (laser iridotomy [LI]) to open the drainage angle, and often eye drops are required as an adjunct to LI to further reduce the IOP. There are several types of drops used to lower IOP but prostaglandin and beta-blocker treatments are the most commonly used. If the drainage pathway is still closed after LI, alternative laser treatment whereby iris tissue is pulled away from the drainage angle, laser peripheral iridoplasty (LPI) is an option. If these first line treatments fail glaucoma filtration surgery (trabeculectomy) is then indicated. Trabeculectomy may fail to control the IOP, and in PACG complications are more likely (such as flat anterior chamber and malignant glaucoma) than for other types of glaucoma. These standard approaches to PACG management have been noted to have variable success.


^ top

Publications

The PURE publications system is currently unavailable. Please try again later.

update

back